By proceeding, you agree to our Terms of Use and Privacy Policy.
It is an exciting time for the microbiome industry and recent FDA approvals and successful fundraising point towards the industry’s potential for therapeutic applications. Developments in the Skin space such as partnerships, collaboration, and licensing agreements, are all designed to boost companies’ product ranges. For example, in 2022 BioGaia and Skinome agreed to research and develop a product to support the skin microbiome. A recent report predicts that the global microbiome skincare products market, valued at USD 381.5 million in 2022 will grow at a compound annual growth rate (CAGR) of 10.9% from 2023 to 2030. The Skin Microbiome & Cosmeceuticals Congress: USA explores the burgeoning field of skin microbiome research and included case studies focusing on a range of skin conditions such as atopic dermatitis, psoriasis, eczema, acne, allergy, wounds, beauty, scalp, immune system, and anti-aging as well as discovering the progress of clinical trials of microbiome-based products being developed to fight these diseases.
Discover the new developments and trends in skin microbiome research.
Gain more profound knowledge of skin health & the microbiome, cosmetics and commercial strategy probiotics & prebiotics, microbiome–the gut and more.
Walk into interactive sessions and discussions to understand how restoring harmonious interactions among microbes is a powerful treatment strategy for skin disease.
Elevate your expertise through industry stalwarts to discover the progress of clinical trials of microbiome-based products being developed to fight skin diseases.
Producing high level conferences and summits for the Pharmaceutical, Medical and Agricultural Biotechnology sectors our experienced team of researchers provides you with the opportunity to share knowledge, network and most importantly find sources of
Labskin’s Fibrin Gel matrix is the only commercially available laboratory-grown full thickness human skin test platform that creates new collagen production and shows the impact on your skin’s microflora balance of cosmetic and skin care products.
Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health.
Founded in 1951 by pharmacists and microbiologists, biose® has 60-year experience in drug based on live bacteria, giving us a deep understanding of the entire process from discovery to commercialization.
Founded in 2019, Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners with companies seeking to develop and manufacture complex biological drugs and innovative therapies.
“EzBiome, Inc. is a microbiome company promising the discovery of exciting new biology and transformative therapeutics through data- and database-driven microbial taxonomy, new bacterial species concept and standard, and the use of carefully curated
“EzBiome, Inc. is a microbiome company promising the discovery of exciting new biology and transformative therapeutics through data- and database-driven microbial taxonomy, new bacterial species concept and standard, and the use of carefully curated and expert validated reference database that inclu
TNO is an independent organisation for applied research. We connect people and knowledge to create innovations that boost the competitive strength of industry and the well-being of society in a sustainable way. Our goal is to connect, change and acce
TNO is an independent organisation for applied research. We connect people and knowledge to create innovations that boost the competitive strength of industry and the well-being of society in a sustainable way. Our goal is to connect, change and accelerate: Innovation for life.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.